EP08.02-019 Phase 1/2 Study of BLU-701, a Highly Selective EGFR Inhibitor, in Patients With EGFR-Mutant Non-Small Cell Lung Cancer
- Resource Type
- Source
- Journal of Thoracic Oncology. 17:S406
- Subject
Pulmonary and Respiratory Medicine Oncology - Language
- ISSN
- 1556-0864